2025 Q4 Quarterly Activities Report & Appendix 4C
Filed with ASX · · 11 pages · English
• Underlying EBITDA2 of $1.6m up vs $0.5m in the prior year and at the top end of guidance of $1.3m to $1.6m. Financial Highlights • Q4 FY25 revenue of $8.1m, up 33% vs pcp. • Q4 FY25 recurring revenue of $7.6m, up 25% vs pcp excluding the Q4 FY25 one-off of $0.47m. • FY25 revenue of $29.0m, up 10% vs pcp and up 6% on a constant currency basis3 • FY25 recurring revenue of $28.5m, up 11% on a like
Story so far
Earlier from ImExHS
- 2025 Q3 Quarterly Activities Report & Appendix 4C
- IMEXHS signs new radiology services contract
- 1H FY25 Results Investor Presentation
- IMEXHS reports 1H F25 Results
- Half Yearly Report and Accounts
Later from ImExHS
- Appendix 4E & Annual Report 2025
- IMEXHS Reports FY25 Results
- IMEXHS FY25 Investor Presentation
- IMEXHS launches agentic AI platform for radiology
- FY26 Q1 Quarterly Activities Report and Appendix 4C
Follow ImExHS into a list and get an email when it puts out news.
Follow ImExHS